N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide

C116H106Cl2F3N21O15S4 — CID 159546465

IUPACN-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide
SMILESCn1c(=O)c2c(CC(=O)Nc3ccn(-c4ccc(Cl)cc4)n3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4ccc(C(C)(C)C)cc4)cs3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4ccc(C(F)(F)F)cc4)cs3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4ccc(C5CCCCC5)cc4)cs3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4cccc(Cl)c4)cs3)cccc2n(C)c1=O
InChIInChI=1S/C27H28N4O3S.C25H26N4O3S.C22H17F3N4O3S.C21H18ClN5O3.C21H17ClN4O3S/c1-30-22-10-6-9-20(24(22)25(33)31(2)27(30)34)15-23(32)29-26-28-21(16-35-26)19-13-11-18(12-14-19)17-7-4-3-5-8-17;1-25(2,3)17-11-9-15(10-12-17)18-14-33-23(26-18)27-20(30)13-16-7-6-8-19-21(16)22(31)29(5)24(32)28(19)4;1-28-16-5-3-4-13(18(16)19(31)29(2)21(28)32)10-17(30)27-20-26-15(11-33-20)12-6-8-14(9-7-12)22(23,24)25;1-25-16-5-3-4-13(19(16)20(29)26(2)21(25)30)12-18(28)23-17-10-11-27(24-17)15-8-6-14(22)7-9-15;1-25-16-8-4-6-13(18(16)19(28)26(2)21(25)29)10-17(27)24-20-23-15(11-30-20)12-5-3-7-14(22)9-12/h6,9-14,16-17H,3-5,7-8,15H2,1-2H3,(H,28,29,32);6-12,14H,13H2,1-5H3,(H,26,27,30);3-9,11H,10H2,1-2H3,(H,26,27,30);3-11H,12H2,1-2H3,(H,23,24,28);3-9,11H,10H2,1-2H3,(H,23,24,27)
InChIKeyMEVUJLTULVJXBP-UHFFFAOYSA-N
MW2290.42 g/mol
LogP17.44
Rot. Bonds21

About N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide

N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide (PubChem CID 159546465) has the molecular formula C116H106Cl2F3N21O15S4 and a molecular weight of 2290.42 g/mol. Its IUPAC name is N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide.

Molecular Properties

Compound NameN-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide
PubChem CID159546465
Molecular FormulaC116H106Cl2F3N21O15S4
Molecular Weight2290.42 g/mol
Exact Mass2287.64
IUPAC NameN-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide
SMILESCn1c(=O)c2c(CC(=O)Nc3ccn(-c4ccc(Cl)cc4)n3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4ccc(C(C)(C)C)cc4)cs3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4ccc(C(F)(F)F)cc4)cs3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4ccc(C5CCCCC5)cc4)cs3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4cccc(Cl)c4)cs3)cccc2n(C)c1=O
InChIInChI=1S/C27H28N4O3S.C25H26N4O3S.C22H17F3N4O3S.C21H18ClN5O3.C21H17ClN4O3S/c1-30-22-10-6-9-20(24(22)25(33)31(2)27(30)34)15-23(32)29-26-28-21(16-35-26)19-13-11-18(12-14-19)17-7-4-3-5-8-17;1-25(2,3)17-11-9-15(10-12-17)18-14-33-23(26-18)27-20(30)13-16-7-6-8-19-21(16)22(31)29(5)24(32)28(19)4;1-28-16-5-3-4-13(18(16)19(31)29(2)21(28)32)10-17(30)27-20-26-15(11-33-20)12-6-8-14(9-7-12)22(23,24)25;1-25-16-5-3-4-13(19(16)20(29)26(2)21(25)30)12-18(28)23-17-10-11-27(24-17)15-8-6-14(22)7-9-15;1-25-16-8-4-6-13(18(16)19(28)26(2)21(25)29)10-17(27)24-20-23-15(11-30-20)12-5-3-7-14(22)9-12/h6,9-14,16-17H,3-5,7-8,15H2,1-2H3,(H,28,29,32);6-12,14H,13H2,1-5H3,(H,26,27,30);3-9,11H,10H2,1-2H3,(H,26,27,30);3-11H,12H2,1-2H3,(H,23,24,28);3-9,11H,10H2,1-2H3,(H,23,24,27)
InChIKeyMEVUJLTULVJXBP-UHFFFAOYSA-N
XLogP17.44
TPSA434.88 Ų
H-Bond Donors5
H-Bond Acceptors35
Rotatable Bonds21
Heavy Atoms161
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002290.42
LogP ≤ 517.44
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1035

Analyze N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide?
The IUPAC name of N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide (CID 159546465) is N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide.
What is the SMILES notation for N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide?
The canonical SMILES for N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide is Cn1c(=O)c2c(CC(=O)Nc3ccn(-c4ccc(Cl)cc4)n3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4ccc(C(C)(C)C)cc4)cs3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4ccc(C(F)(F)F)cc4)cs3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4ccc(C5CCCCC5)cc4)cs3)cccc2n(C)c1=O.Cn1c(=O)c2c(CC(=O)Nc3nc(-c4cccc(Cl)c4)cs3)cccc2n(C)c1=O.
What is the InChIKey of N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide?
The InChIKey is MEVUJLTULVJXBP-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H28N4O3S.C25H26N4O3S.C22H17F3N4O3S.C21H18ClN5O3.C21H17ClN4O3S/c1-30-22-10-6-9-20(24(22)25(33)31(2)27(30)34)15-23(32)29-26-28-21(16-35-26)19-13-11-18(12-14-19)17-7-4-3-5-8-17;1-25(2,3)17-11-9-15(10-12-17)18-14-33-23(26-18)27-20(30)13-16-7-6-8-19-21(16)22(31)29(5)24(32)28(19)4;1-28-16-5-3-4-13(18(16)19(31)29(2)21(28)32)10-17(30)27-20-26-15(11-33-20)12-6-8-14(9-7-12)22(23,24)25;1-25-16-5-3-4-13(19(16)20(29)26(2)21(25)30)12-18(28)23-17-10-11-27(24-17)15-8-6-14(22)7-9-15;1-25-16-8-4-6-13(18(16)19(28)26(2)21(25)29)10-17(27)24-20-23-15(11-30-20)12-5-3-7-14(22)9-12/h6,9-14,16-17H,3-5,7-8,15H2,1-2H3,(H,28,29,32);6-12,14H,13H2,1-5H3,(H,26,27,30);3-9,11H,10H2,1-2H3,(H,26,27,30);3-11H,12H2,1-2H3,(H,23,24,28);3-9,11H,10H2,1-2H3,(H,23,24,27).
What are the key properties of N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide?
N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide has a molecular weight of 2290.42 g/mol, XLogP of 17.44, 21 rotatable bonds, 5 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(4-tert-butylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[1-(4-chlorophenyl)pyrazol-3-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(3-chlorophenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;N-[4-(4-cyclohexylphenyl)-1,3-thiazol-2-yl]-2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)acetamide;2-(1,3-dimethyl-2,4-dioxoquinazolin-5-yl)-N-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]acetamide is sourced from PubChem (CID 159546465), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).